Hagstad H
Pharmatherapeutica. 1984;3(10):692-7.
The penetration of ampicillin and amoxycillin into bronchial secretions was investigated by bronchoscopy in 20 patients suffering from exacerbations of chronic bronchitis. Five patients received 500 mg pivampicillin, 8 received 700 mg pivampicillin and 7 received 500 mg amoxycillin. There were no significant differences between these three treatments in respect of the serum and bronchial secretion concentrations at the time of bronchoscopy, nor were there any significant differences in the peak serum level or total bioavailability of each regimen. The concentrations in bronchial secretions, on average, were 5.7%, 9.0% and 7.6% of the corresponding serum concentrations in patients given 500 mg pivampicillin, 700 mg pivampicillin and 500 mg amoxycillin, respectively. The concentration in bronchial secretions exceeded the MIC for sensitive strains of Haemophilus influenzae in more cases treated with pivampicillin than with amoxycillin.
通过支气管镜检查,对20例慢性支气管炎急性加重期患者进行了氨苄西林和阿莫西林在支气管分泌物中的渗透情况研究。5例患者接受500mg匹氨西林治疗,8例接受700mg匹氨西林治疗,7例接受500mg阿莫西林治疗。在支气管镜检查时,这三种治疗方法在血清和支气管分泌物浓度方面无显著差异,各治疗方案的血清峰值水平或总生物利用度也无显著差异。接受500mg匹氨西林、700mg匹氨西林和500mg阿莫西林治疗的患者,其支气管分泌物中的浓度平均分别为相应血清浓度的5.7%、9.0%和7.6%。与阿莫西林相比,更多接受匹氨西林治疗的病例中,支气管分泌物中的浓度超过了流感嗜血杆菌敏感菌株的最低抑菌浓度(MIC)。